18th May 2011
The findings of new research have shown that prostate treatments involving a specific alpha blocker could help reduce symptoms and improve quality of life for men with prostate conditions.
Researchers at the Kingston General Hospital in Canada found that silodosin, which works by selectively relaxing the muscles in the bladder neck and prostate, was particularly effective in relieving the symptoms of chronic prostatis (CP) and chronic pelvic pain syndrome (CPPS).
Sixty per cent of men tested reported feeling better after they had been treated, compared with 30 per cent of men who had been given a placebo.
Lead researcher Curtis Nickel said: "Antibiotics are commonly used as treatment, but are not typically effective, probably because CP/CPPS does not seem to be caused by a bacterial infection."
CP/CPPS is thought to be one of the most common conditions afflicting the prostate. It is characterised by persistent discomfort in the lower pelvic area with severe symptoms, including painful and frequent urination and difficult or painful ejaculation. The cause of the condition is unknown.
Chronic pelvic pain syndrome is thought to affect around nine per cent of all post-pubescent men.
Posted by Philip Briggs
Nickel, J Curtis et al. " Silodosin for Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results of a Phase II Multicenter, Double-Blind, Placebo Controlled Study." Journal of Urology. 16th May 2011.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.